Our data suggest that such therapeutic strategies could be extended to glioblastoma, where a locoregional route of administration may not only improve therapeutic results58, 59 but also take advantage of the identified patterns of FAP expression, which are limited to tumor cells and supporting vascular networks. This evidence concerns the gene FAP and neoplasm.